Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2020 Jan 22;90:105938. doi: 10.1016/j.cct.2020.105938

Figure 2.

Figure 2.

Geographic distribution of enrolling study sites for the trial “Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled phase 3 clinical trial (S31/A5349)”